BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 1640597)

  • 61. [Combined chemotherapy of patients with tuberculosis - new regimens and dosage forms].
    Sokolova GB; Koriakin VA; Khalbaeva IV; Elistratova NA; Ziia AV
    Probl Tuberk; 1993; (5):21-3. PubMed ID: 8295879
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Current views on drug treatment of tuberculosis].
    Repo K; Riska N
    Duodecim; 1970; 86(21):1268-78. PubMed ID: 5490929
    [No Abstract]   [Full Text] [Related]  

  • 63. [Antitubercular chemotherapy].
    Jouveshomme S; Dautzenberg B
    Rev Mal Respir; 1997 Dec; 14 Suppl 5():S88-104. PubMed ID: 9496594
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Beyond multidrug-resistant tuberculosis in Europe: a TBNET study.
    Günther G; van Leth F; Altet N; Dedicoat M; Duarte R; Gualano G; Kunst H; Muylle I; Spinu V; Tiberi S; Viiklepp P; Lange C;
    Int J Tuberc Lung Dis; 2015 Dec; 19(12):1524-7. PubMed ID: 26614196
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antituberculous agents. Isoniazid, rifampin, streptomycin, ethambutol, and pyrazinamide.
    Van Scoy RE; Wilkowske CJ
    Mayo Clin Proc; 1983 Apr; 58(4):233-40. PubMed ID: 6834890
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Therapy of tuberculosis].
    Schaberg T; Lode H
    Dtsch Med Wochenschr; 1990 Nov; 115(47):1799-802. PubMed ID: 2226195
    [No Abstract]   [Full Text] [Related]  

  • 67. [Epidural abscess due to a Mycobacterium tuberculosis strain with primary resistance to isoniazid and ethambutol].
    Sener A; Akçalı A; Karatağ O; Koşar S; Değirmenci Y; Akman T
    Mikrobiyol Bul; 2012 Oct; 46(4):689-94. PubMed ID: 23188583
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Drugs for tuberculosis.
    Med Lett Drugs Ther; 1995 Aug; 37(954):67-70. PubMed ID: 7616907
    [No Abstract]   [Full Text] [Related]  

  • 69. [Experience in treatment of patients with chronic destructive pulmonary tuberculosis in a suburban tuberculosis hospital].
    Sirota DS; Man'kovetskiĭ EF; Koĭfman SG; Vatsyk MZ
    Probl Tuberk; 1974; (10):17-9. PubMed ID: 4370967
    [No Abstract]   [Full Text] [Related]  

  • 70. The chemotherapy of pulmonary tuberculosis: a review.
    Fox W
    Chest; 1979 Dec; 76(6 Suppl):785-96. PubMed ID: 92393
    [No Abstract]   [Full Text] [Related]  

  • 71. [Activity of the second-line preparations, ethambutol and rifampin, in experimental tuberculosis caused by Mycobacterium tuberculosis highly resistant to basic tuberculostatics].
    Golyshevskaia VI; El'shanskaia MP
    Probl Tuberk; 1973; 51(12):60-4. PubMed ID: 4205666
    [No Abstract]   [Full Text] [Related]  

  • 72. [Chemotherapeutic studies on advanced tuberculosis in mice].
    Grumbach F
    Bibl Tuberc; 1965; 21():31-96. PubMed ID: 4301034
    [No Abstract]   [Full Text] [Related]  

  • 73. Drug resistant tuberculosis in prisons in Azerbaijan: case study.
    Coninx R; Pfyffer GE; Mathieu C; Savina D; Debacker M; Jafarov F; Jabrailov I; Ismailov A; Mirzoev F; de Haller R; Portaels F
    BMJ; 1998 May; 316(7142):1423-5. PubMed ID: 9572751
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The impact of chemotherapy on the care of patients with tuberculosis.
    Johnston RF; Wildrick KH
    Am Rev Respir Dis; 1974 Jun; 109(6):636-64. PubMed ID: 4209115
    [No Abstract]   [Full Text] [Related]  

  • 75. [The drug treatment of renal tuberculosis].
    Gartmann JC
    Schweiz Med Wochenschr; 1967 Jul; 97(30):976-9. PubMed ID: 4298882
    [No Abstract]   [Full Text] [Related]  

  • 76. Prevention of tuberculosis in HIV-1.
    Halsey NA; Coberly J; Chaisson R
    Lancet; 1998 Aug; 352(9129):742. PubMed ID: 9729026
    [No Abstract]   [Full Text] [Related]  

  • 77. [A comparison of the time of in vivo resistance development of tubercle bacilli to rifampicin, kanamycin, ethionamide, lividomycin, and enviomycin (tuberactinomycin-N) in patients with chronic cavitary tuberculosis (author's transl)].
    Tsukamura M
    Kekkaku; 1978 Oct; 53(10):495-8. PubMed ID: 102861
    [No Abstract]   [Full Text] [Related]  

  • 78. Drug resistance trends among previously treated tuberculosis patients in a national registry in Peru, 1994-2001.
    Vásquez-Campos L; Asencios-Solis L; Leo-Hurtado E; Quispe-Torres N; Salazar-Lindo E; Bayona J; Becerra MC
    Int J Tuberc Lung Dis; 2004 Apr; 8(4):465-72. PubMed ID: 15141740
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).
    Negi SS; Gupta S; Lal S
    J Commun Dis; 2003 Jun; 35(2):74-81. PubMed ID: 15562952
    [TBL] [Abstract][Full Text] [Related]  

  • 80. CDC recommends four-drug treatment of tuberculosis in multidrug-resistant era.
    Am Fam Physician; 1993 Sep; 48(4):671-2. PubMed ID: 8397483
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.